Roivant Sciences(ROIV) - 2026 Q2 - Earnings Call Transcript

Roivant Sciences (NasdaqGS:ROIV) Q2 2026 Earnings Call November 10, 2025 08:00 AM ET Company ParticipantsCorinne Johnson - VP of Equity ResearchMatt Gline - CEOStephanie Lee - Head of Investor RelationsBrandon Frith - AssociateConference Call ParticipantsNone - AnalystNone - AnalystThomas Smith - Senior Research AnalystRon Werber - Managing Director and Senior Biotechnology AnalystBrian Cheng - Biotech AnalystDennis Ding - Biotech Equity Research AnalystDavid Risinger - Senior Managing Director and Senior R ...